Biblio Discovery — Demo Discovery Service

4 results for "Fuchs, Adrian V."

Showing 1–4 · 0.09 seconds · RSS

  1. Journal Article Full text

    Reversible activation of pH-sensitive cell penetrating peptides attached to gold surfaces()

    Baio, Joe E.; Schach, Denise; Fuchs, Adrian V. et al.

    Chem Commun (Camb) · 2015 · English · PubMed Central

    pH-sensitive viral fusion protein mimics are widely touted as a promising route towards site-specific delivery of therapeutic compounds across lipid membranes. Here, we demonstrate that a fusion protein mimic, designed to achieve a reversible, pH-driven helix-coil transition mechanism, retains its…

  2. Journal Article Full text

    Targeted and modular architectural polymers employing bioorthogonal chemistry for quantitative therapeutic delivery

    Ediriweera, Gayathri R.; Simpson, Joshua D.; Fuchs, Adrian V. et al.

    Chem Sci · 2020 · English · PubMed Central

    There remain several key challenges to existing therapeutic systems for cancer therapy, such as quantitatively determining the true, tissue-specific drug release profile in vivo, as well as reducing side-effects for an increased standard of care. Hence, it is crucial to engineer new materials that…

  3. Journal Article Full text

    Understanding the Uptake of Nanomedicines at Different Stages of Brain Cancer Using a Modular Nanocarrier Platform and Precision Bispecific Antibodies

    Houston, Zachary H.; Bunt, Jens; Chen, Kok-Siong et al.

    ACS Cent Sci · 2020 · English · PubMed Central

    [Image: see text] Increasing accumulation and retention of nanomedicines within tumor tissue is a significant challenge, particularly in the case of brain tumors where access to the tumor through the vasculature is restricted by the blood–brain barrier (BBB). This makes the application of…

  4. Journal Article Full text

    EphA3 Pay-Loaded Antibody Therapeutics for the Treatment of Glioblastoma

    Offenhäuser, Carolin; Al-Ejeh, Fares; Puttick, Simon et al.

    Cancers (Basel) · 2018 · English · PubMed Central

    The EphA3 receptor has recently emerged as a functional tumour-specific therapeutic target in glioblastoma (GBM). EphA3 is significantly elevated in recurrent disease, is most highly expressed on glioma stem cells (GSCs), and has a functional role in maintaining self-renewal and tumourigenesis. An…